Company profile: Ascopharm
1.1 - Company Overview
Company description
- Provider of high-quality nutritional supplements, OTC drugs, minerals, vitamins, and cosmetic products, including sovita Vitamin D, Multi Vitamin + Mineral, B-Complex, Vitamin C 300 long-term, Melatonin Plus Spray, and Vitamin B12 Opti 100 formulations supporting bone health, immune function, energy metabolism and production, nervous system and neurological function, antioxidant protection, and sleep regulation.
Products and services
- Sovita Melatonin Plus Spray: An oral-spray formulation that delivers melatonin to aid sleep regulation, packaged as a spray for straightforward administration (oral-spray)
- Sovita Multi Vitamin + Mineral Tablets: Tablet assemblies supplying a combination of essential vitamins and minerals for overall health in an oral tablet dosage form (multi-nutrient)
- Sovita Vitamin B-Complex Capsules: Capsule components containing a range of B vitamins to support energy metabolism and nervous system health in an oral capsule format (capsule-based)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ascopharm
DoctorsForMe
HQ: United States
Website
- Description: Provider of data-driven doctor-matching services helping patients with cancer and other complex conditions find the right physicians by measuring doctors’ expertise and clinical excellence through analysis of billions of data points.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DoctorsForMe company profile →
Greenspace Health
HQ: Canada
Website
- Description: Provider of evidence-based mental health technology, including a Measurement-Based Care platform to track patient-reported outcomes and improve treatment outcomes, a Pop Health platform offering self-guided resources and data-driven insights for large populations, over 350 customizable assessment tools, and integration services with 85+ EHR/EMR systems, all with a strong focus on data security and privacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Greenspace Health company profile →
NHS
HQ: United Kingdom
Website
- Description: Provider of UK government-funded healthcare information and services, including detailed content on medical conditions, symptoms, treatments, and preventive care to support informed health decisions. Offers tools to locate NHS services such as GPs and hospitals, and a national secure collaboration service for health and social care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NHS company profile →
Sesame
HQ: United States
Website
- Description: Provider of quality, convenient health care services for Americans at half the typical price.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sesame company profile →
Talkspace
HQ: United States
Website
- Description: Provider of digital therapy services, including online therapy, online counseling, psychiatry and medication management, and self-care. Offers confidential therapy through a network of licensed therapists, with unlimited messaging therapy that provides access to a licensed professional without appointments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Talkspace company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ascopharm
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ascopharm
2.2 - Growth funds investing in similar companies to Ascopharm
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ascopharm
4.2 - Public trading comparable groups for Ascopharm
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →